• Perospirone Inhibits Vascular Kv1.5 Channels: Implications f

  2026-06-02

  A recent study demonstrates that Perospirone, an atypical antipsychotic, directly inhibits vascular Kv1.5 potassium channels in coronary arterial smooth muscle cells independently of its classical receptor targets. These findings have important implications for both schizophrenia research and cardiovascular safety assessments when using Perospirone in experimental models.

• Catalpol in Translational Disease Models: Protocols & Pitfal

  2026-06-02

  Catalpol, a multi-target iridoid glycoside, enables advanced neuroprotection and disease modeling by modulating key pathways such as VEGF-PI3K/AKT. This article delivers actionable workflows, troubleshooting strategies, and evidence-driven insights for optimizing Catalpol-based protocols across neuroprotection, osteoporosis, ischemic stroke, and liver fibrosis research.

• Lipid Scrambling by TMEM16F Regulates Ferroptosis and Tumor

  2026-06-01

  Yang et al. reveal that TMEM16F-mediated lipid scrambling functions as a key suppressor in the execution phase of ferroptosis by remodeling plasma membrane phospholipids. Disruption of this process enhances ferroptotic cell death and potentiates antitumor immune responses, suggesting new avenues for targeted cancer therapies.

• RapaLink-1: Third-Generation mTOR Inhibitor for Dormancy and

  2026-06-01

  RapaLink-1 sets a new benchmark in mTOR pathway modulation, overcoming resistance mutations and enabling robust, reproducible induction of cellular dormancy in both cancer and developmental biology models. This guide translates the latest protocol innovations and troubleshooting insights into actionable workflows for advanced researchers.

• 4-Hydroxytamoxifen Protocol Guidance for Cancer & Cardiac Re

  2026-05-31

  4-Hydroxytamoxifen is a high-purity estrogen receptor modulator used in breast and prostate cancer research, as well as cardiac myocyte calcium handling studies. It is strictly suited for DMSO-based protocols and should not be used where aqueous or ethanol solubility is required.

• LPS/TLR4/YAP1 Axis Maintains Hepatocyte Stemness in the Port

  2026-05-30

  Shao et al. (2021) demonstrate that high portal vein lipopolysaccharide (LPS) sustains the stemness of hepatocytes by activating YAP1 signaling via TLR4. This discovery clarifies a key mechanism in hepatic regeneration and suggests new experimental avenues for modulating hepatocyte plasticity in liver repair models.

• LY2109761: Defining the Next Frontier in TGF-β Dual Inhibiti

  2026-05-29

  Explore how LY2109761, a potent TGF-β receptor type I and II dual inhibitor, is transforming preclinical cancer and fibrosis research through precision kinase modulation and Smad2/3 pathway targeting. This article delivers advanced insight beyond mechanism, focusing on translational impact and assay innovation.

• QPRT Drives Breast Cancer Invasion via PLC-Dependent Pathway

  2026-05-29

  This study establishes quinolinate phosphoribosyltransferase (QPRT) as a promoter of breast cancer cell invasiveness via myosin light chain phosphorylation and PLC-mediated signaling. The findings reveal mechanistic links between NAD+ metabolism and cytoskeletal dynamics, highlighting new avenues for targeting metastatic progression.

• GW4064: Non-Steroidal FXR Agonist for Advanced Metabolic Ass

  2026-05-28

  GW4064 (APExBIO, SKU B1527) empowers metabolic and fibrosis researchers to dissect FXR-driven pathways with high selectivity and reproducibility. Its bench-proven potency and workflow versatility set a new standard for studying lipid metabolism, bile acid regulation, and fibroblast activation.

• Alternariol Drives Hepatic Stellate Transdifferentiation in

  2026-05-28

  This study elucidates how Alternariol (AOH) and related Alternaria toxins directly induce hepatic stellate cell transdifferentiation, a central event in liver fibrosis. By integrating lncRNA-mRNA omics and mechanistic pathway analysis, the research advances understanding of Alternaria mycotoxin hepatotoxicity and highlights a promising CotA laccase detoxification strategy.

• Selective IMPDH2 Inhibition by Berberrubine in Colorectal Ca

  2026-05-27

  The referenced study identifies berberrubine as a novel and selective inhibitor of IMPDH2, a key enzyme implicated in colorectal cancer (CRC) proliferation and poor patient prognosis. Through both in vitro and in vivo experiments, the research demonstrates that berberrubine impairs CRC growth via selective enzymatic targeting, highlighting its potential as an anti-colorectal cancer agent.

• PKM2 Inhibitor (Compound 3k): Selective Disruption of Tumor

  2026-05-27

  PKM2 inhibitor (compound 3k) is a potent, selective small molecule targeting pyruvate kinase M2, disrupting aerobic glycolysis in tumor cells and modulating macrophage polarization. It demonstrates nanomolar antiproliferative activity in key cancer cell lines and shows high selectivity over normal cells. Recent evidence confirms its efficacy in both oncology and immunometabolism models.

• Applied Use of PPT (Propyl Pyrazole Triol) in ERα Signaling

  2026-05-26

  PPT (Propyl Pyrazole Triol) redefines estrogen receptor alpha (ERα) research with unmatched selectivity and proven workflow consistency. Discover how this compound advances assays from gene expression to in vivo modeling, with practical troubleshooting and actionable protocol enhancements.

• Eliminating Pollen Interference in Bioaerosol Spectral Analy

  2026-05-26

  The reference study introduces an advanced approach to remove pollen-induced spectral interference in excitation–emission matrix (EEM) fluorescence spectroscopy, significantly improving hazardous bioaerosol classification accuracy. This innovation holds practical importance for research in environmental biosurveillance and rapid detection of pathogenic substances.

• JNJ-10198409: Precision Platelet-Derived Growth Factor Recep

  2026-05-25

  JNJ-10198409 stands out as a best-in-class platelet-derived growth factor receptor inhibitor, enabling researchers to dissect PDGF-driven biology in oncology, fibrosis, and angiogenesis with unprecedented specificity and reproducibility. Streamlined protocols, robust nanomolar potency, and actionable troubleshooting guidance make it a cornerstone for translational research.

16304 records 1/1087 page Next 12345 下5页 Last page